News & Events about Nrx Pharmaceuticals Inc.
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements PR Newswire GENEVA and RADNOR, Pa., Dec. 20, 2022 Ad hoc announcement...
GENEVA, SWITZERLAND and RADNOR, PA / ACCESSWIRE / December 20, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ('Relief'), and NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals'), a clinical-stage central nervous system biopharmaceutical...
NRx Receives Nasdaq Notice of Listing Compliance NRx Receives Nasdaq Notice of Listing Compliance PR Newswire RADNOR, Pa., Dec. 2, 2022 RADNOR, Pa., Dec. 2, 2022 /PRNewswire/ --NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ('NRx Pharmaceuticals', the 'Company'), a clinical-stage...
GENEVA, SWITZERLAND and RADNOR, PA / ACCESSWIRE / November 14, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTD) (' Relief '), and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) (' NRx Pharmaceuticals '), today announced that they have entered into definitive...
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements PR Newswire GENEVA and RADNOR, Pa., Nov. 14, 2022 Ad hoc...